BHCM
APEN

Boulder Hill Capital Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Boulder Hill Capital Management’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,400
Closed -$96K – 264
2021
Q4 		$96K Buy
+11,400
New +$99.6K 0.09% 150

Other funds holding APEN

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Boulder Hill Capital Management's APEN Position: Q1 2022 in Review

Boulder Hill Capital Management sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2022, closing a stake of 11,400 shares — an estimated $96K sold.

Boulder Hill Capital Management first reported a position in APEN in Q4 2021 and held it in 1 quarter. The position peaked at $96K in Q4 2021. 71 funds tracked by Wall St. Rank hold APEN as of Q1 2022.

  • Boulder Hill Capital Management reported no remaining Apollo Endosurgery, Inc. position as of Q1 2022 after selling out during the quarter.
  • Boulder Hill Capital Management sold 11,400 Apollo Endosurgery, Inc. shares in Q1 2022, an estimated $96K.
  • Boulder Hill Capital Management first reported a position in Apollo Endosurgery, Inc. in Q4 2021 and held it in 1 quarter.
  • Boulder Hill Capital Management's Apollo Endosurgery, Inc. position peaked at $96K in Q4 2021.
  • 71 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2022.

Based on Boulder Hill Capital Management's 13F filing for Q1 2022, filed 12 May 2022.